Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Megan Miller

Showing results (71-80 of 123) with videos related to

Pageof 13
Sort By:
Viruses|November 27, 2024
Evaluation of Fecal Sample Pooling for Real-Time RT-PCR Testing SARS-CoV-2 in AnimalsAntonio Leonardi-Cattolica, Sandipty Kayastha, Megan Miller, et al.
Journal of Surgical Education|November 12, 2013
Implementing an excellence in teaching recognition system: needs analysis and recommendationsNancy Schindler, Julia C Corcoran, Megan Miller, et al.
Journal of General Internal Medicine|October 22, 2024
Toward a Consensus on Strategies to Support Opioid Use Disorder Care Transitions Following Hospitalization: A Modified Delphi ProcessNoa Krawczyk, Megan Miller, Honora Englander, et al.
Child: Care, Health and Development|August 10, 2022
Experiences of medical traumatic stress in parents of children with medical complexityTammie Dewan, Katie Birnie, Julie Drury, et al.
The Journal of Dermatological Treatment|July 15, 2020
Continuous treatment with guselkumab maintains clinical responses through 4 years in patients with moderate-to-severe psoriasis: results from VOYAGE 1Christopher E M Griffiths, Kim A Papp, Michael Song, et al.
American Journal of Clinical Dermatology|September 10, 2020
Maintenance of Response Through up to 4 Years of Continuous Guselkumab Treatment of Psoriasis in the VOYAGE 2 Phase 3 StudyKristian Reich, April W Armstrong, Peter Foley, et al.
Addiction Science & Clinical Practice|July 2, 2026
"It's so much easier for them to just come to us": a qualitative study examining the implementation of mobile methadone treatment serving a residential SUD treatment programDavid Frank, Samantha J Harris, Minna Song, et al.
Neuroepidemiology|December 1, 2021
A Multicentre Study Comparing Cerebrovascular Disease Profiles in Pacific Islander and Caucasian Populations Presenting with Stroke and Transient Ischaemic AttackChristopher Blair, Angela Firtko, Peter Thomas, et al.
BMC Gastroenterology|March 8, 2023
Food elimination diet is a viable alternative therapy for eosinophilic esophagitis responsive to proton pump inhibitorsTwan Sia, Evan Cunningham, Megan Miller, et al.
Dermatology and Therapy|August 23, 2024
Direct and Indirect Effect of Guselkumab on Anxiety, Depression, and Quality of Life in Patients with Moderate-to-Severe Plaque Psoriasis: A Mediation AnalysisApril W Armstrong, Peter Foley, Yan Liu, et al.
Pageof 13

Showing results (71-80 of 123) with videos related to

Sort By:
Pageof 13
Viruses|November 27, 2024
Evaluation of Fecal Sample Pooling for Real-Time RT-PCR Testing SARS-CoV-2 in AnimalsAntonio Leonardi-Cattolica, Sandipty Kayastha, Megan Miller, et al.
Journal of Surgical Education|November 12, 2013
Implementing an excellence in teaching recognition system: needs analysis and recommendationsNancy Schindler, Julia C Corcoran, Megan Miller, et al.
Journal of General Internal Medicine|October 22, 2024
Toward a Consensus on Strategies to Support Opioid Use Disorder Care Transitions Following Hospitalization: A Modified Delphi ProcessNoa Krawczyk, Megan Miller, Honora Englander, et al.
Child: Care, Health and Development|August 10, 2022
Experiences of medical traumatic stress in parents of children with medical complexityTammie Dewan, Katie Birnie, Julie Drury, et al.
The Journal of Dermatological Treatment|July 15, 2020
Continuous treatment with guselkumab maintains clinical responses through 4 years in patients with moderate-to-severe psoriasis: results from VOYAGE 1Christopher E M Griffiths, Kim A Papp, Michael Song, et al.
American Journal of Clinical Dermatology|September 10, 2020
Maintenance of Response Through up to 4 Years of Continuous Guselkumab Treatment of Psoriasis in the VOYAGE 2 Phase 3 StudyKristian Reich, April W Armstrong, Peter Foley, et al.
Addiction Science & Clinical Practice|July 2, 2026
"It's so much easier for them to just come to us": a qualitative study examining the implementation of mobile methadone treatment serving a residential SUD treatment programDavid Frank, Samantha J Harris, Minna Song, et al.
Neuroepidemiology|December 1, 2021
A Multicentre Study Comparing Cerebrovascular Disease Profiles in Pacific Islander and Caucasian Populations Presenting with Stroke and Transient Ischaemic AttackChristopher Blair, Angela Firtko, Peter Thomas, et al.
BMC Gastroenterology|March 8, 2023
Food elimination diet is a viable alternative therapy for eosinophilic esophagitis responsive to proton pump inhibitorsTwan Sia, Evan Cunningham, Megan Miller, et al.
Dermatology and Therapy|August 23, 2024
Direct and Indirect Effect of Guselkumab on Anxiety, Depression, and Quality of Life in Patients with Moderate-to-Severe Plaque Psoriasis: A Mediation AnalysisApril W Armstrong, Peter Foley, Yan Liu, et al.
Pageof 13